Renal transplant outcome in high-cardiovascular risk recipients

Tarun K Jeloka1, Heather Ross, Robert Smith

  • 1Renal Transplant Programme, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.

Clinical Transplantation
|September 12, 2007
PubMed

Insights

High-CV risk renal transplant recipients with known coronary artery disease (CAD) have lower survival rates. While cardiac interventions may lower perioperative risk, they do not eliminate post-transplant cardiac events.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Cardiovascular disease is a leading cause of death and illness in renal transplant recipients.
  • The prevalence of cardiovascular disease is expected to rise with the acceptance of older patients for transplantation.
  • Outcomes for high-CV risk patients, particularly those with pre-existing coronary artery disease (CAD), post-renal transplantation are not well-documented.

Purpose of the Study:

  • To investigate the cardiovascular outcomes in renal transplant recipients with known pre-transplant coronary artery disease (CAD).
  • To compare post-transplant cardiac events and survival rates between high-risk and low-risk patient groups.
  • To identify predictors of post-transplant cardiac events in renal transplant recipients.

Main Methods:

  • A retrospective analysis of renal transplants performed between 1998 and 2002, with follow-up until 2005.
  • Patients were stratified into high-risk (pre-transplant angina, myocardial infarction, or positive coronary angiogram) and low-risk groups.
  • Cox-regression multivariate analysis was employed to determine predictors of post-transplant cardiac events.

Main Results:

  • 10.5% of 429 patients experienced post-transplant cardiac events, with significantly higher rates in the high-risk group (31.3%) versus the low-risk group (6.5%).
  • Five-year patient survival was lower in the high-risk group (82.8%) compared to the low-risk group (93.1%).
  • Age, pre-transplant cardiac disease, arrhythmias, and low ejection fraction (<40%) were identified as independent predictors of post-transplant cardiac events.

Conclusions:

  • Renal transplant recipients with known CAD (high-CV risk) exhibit reduced post-transplant survival compared to low-risk recipients, though survival remains acceptable.
  • Pre-transplant cardiac interventions may mitigate perioperative risks but do not reduce the incidence of post-transplant cardiac events to levels seen in the low-risk group.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...